Eiji Kawaminami

This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Astellas Pharma Gmbh, Yamanouchi Pharmaceutical Company Ltd.. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eiji Kawaminami. Retrieved from https://idiyas.com/inventor/eiji-kawaminami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 7)

% Patents Active = 61.5

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 8.1

ph-index = 6

Forward Citations = 115(Granted Patents)

Location History:

Ibaraki, JP (1996 - 2004)
Tsukuba, JP (2005 - 2009)
Chuo-ku, JP (2010 - 2011)
Tokyo, JP (2011 - 2014)

Company Filing History:

Yamanouchi Pharmaceutical Company Ltd.

patents

Years Active: 1996-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729206 - 4-aminoquinazoline compound (2026-09-08),

2. 12384794 - Quinazoline compound for inducing degradation of G12D mutant KRAS protein (2025-08-12),

3. 8815920 - Substituted amide compound (2014-08-26),

4. 8669246 - Substituted amide compound (2014-03-11),

5. 8076367 - Benzimidazolylidene propane-1,3-dione derivative or salt thereof (2011-12-13),

6. 7960562 - Propane-1,3-dione derivative or salt thereof (2011-06-14),

7. 7709519 - Benzimidazolylidene propane-1,3 dione derivative or salt thereof (2010-05-04),

8. 7569688 - Propane-1, 3-dione derivative (2009-08-04),

9. 6960591 - Propane-1,3-dione derivative (2005-11-01),

10. 6673799 - Cyanophenyl derivative (2004-01-06),

11. 5807880 - Azole derivative and pharmaceutical composition thereof (1998-09-15),

12. 5674886 - Triazolylated teritiary amine compound or salt thereof (1997-10-07),

13. 5538976 - Substituted tertiary amino compound or salt thereof (1996-07-23),

Title: Eiji Kawaminami: Innovator in Pharmaceutical Chemistry

Introduction

Eiji Kawaminami, an esteemed inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio that includes 11 patents, Kawaminami specializes in developing innovative compounds that address various medical conditions.

Latest Patents

Among his latest inventions is a substituted amide compound, which serves as an active ingredient in pharmaceutical compositions. This compound is particularly aimed at treating diseases associated with lysophosphatidic acid (LPA). The compound's formula features complex structural components, including optionally substituted aryl groups and aromatic hetero ring groups, showcasing Kawaminami's expertise in creating sophisticated chemical solutions.

Career Highlights

Kawaminami has built his career through collaborations with prominent companies in the pharmaceutical industry. Notably, he has worked with Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd., where he contributed to groundbreaking research and development initiatives.

Collaborations

Throughout his career, Kawaminami has had the privilege of collaborating with talented individuals like Masaaki Hirano and Minoru Okada. These partnerships have enriched his work, allowing for the exchange of ideas and innovations that advance pharmaceutical science.

Conclusion

Eiji Kawaminami stands out as a pivotal figure in the realm of pharmaceutical inventions. With a strong emphasis on developing vital compounds for medical use, his contributions continue to resonate within the industry. As he progresses in his career, Kawaminami's work is poised to impact the field of medicine substantially, demonstrating the power of innovation in addressing health challenges.

Profile summary based on public USPTO records.